On Tuesday, Following U.S. Stocks were among the “Top Losers”: VASCO Data Security International, Inc (NASDAQ:VDSI), InspireMD (NYSEMKT:NSPR), Merrimack Pharmaceuticals (NASDAQ:MACK), Pioneer Energy Services (NYSE:PES)
VASCO Data Security International, Inc (NASDAQ:VDSI)’s shares dwindled -6.35%, and closed at $1.54. The stock volatility for the week is 4.46%, while for the month remained 6.73%. The company holds consensus target price of $38.50.
If we consider EPS growth of the company, then we will notice the following observations:
The company showed 0.83 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 196.40%, and Annual EPS growth for the past 5 years is considered as 21.80%.
The mean recommendation of analysts for this stock is 1.50. (where 1=Buy, 5=Sale).
Coeur Mining, Inc., through its subsidiaries, engages in the ownership, operation, exploration, and development of silver and gold mining properties primarily in the United States, Mexico, Bolivia, Argentina, Australia, Ecuador, Chile, and New Zealand
VASCO Data Security International, Inc., together with its subsidiaries, designs, develops, and markets security systems to secure and manage access to user digital assets worldwide.
InspireMD Inc (NYSEMKT:NSPR), declined -6.32%, and closed at $0.280. The stock has price to sale value of 3.50. With recent decline, the year-to-date (YTD) performance reflected a -62.16% decline below last year. During the past month the stocks lose -62.67%, bringing three-month performance to -72% and six-month performance to -88.33%. The mean recommendation of analysts for this stock is 1.70. (where 1=Buy, 5=Sale).
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its MGuard stent is an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK), dipped -6.32%, and closed at $11.27. The company holds the market capitalization of 1.29B. For the trailing twelve months, the stock’s return on equity value remains 96.60%, while return on assets value is -51.90%, in response to its return on investment value of -367.80%. Its 20-day moving average gained 3.89%, above 50-day moving average of 6.40%, above 200-day moving average of 32.14% from the latest market price of $11.27. The mean recommendation of analysts for this stock is 1.60.(where 1=Buy, 5=Sale).
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.
Pioneer Energy Services Corp (NYSE:PES), dropped -6.26%, and closed at $4.94. The stock has the beta value of 2.45, and its volatility for the week is 6.86%, while for the month it is 8.14%. The company has the market capitalization of $ 336.58M. The company holds the book value per share of 7.76, whereas cash per share is 0.55. Price to book value is estimated to be 0.64, while price to sale value is 0.30. Analysts mean recommendation for the stock is said to be 2.80 (where 1=Buy, 5=sale).
Pioneer Energy Services Corp., through its subsidiaries, provides drilling services and production services to oil and gas exploration and production companies in the United States and Colombia. The company’s Drilling Services Segment provides contract land drilling services in Texas, North Dakota, Utah, Appalachia, and Colombia.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content of this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
